NIOX Group PLC CSSPF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 420.87M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 32.09
- Price/Sales
- 6.01
- Dividend Yield (Trailing)
- 2.28%
- Dividend Yield (Forward)
- 2.28%
- Dividend Payment Schedule
- Jun
- Total Yield
- 2.28%
Company Profile
NIOX Group PLC is engaged in improving the diagnosis, monitoring and management of both asthma and COPD by providing greater patient access to FeNO testing. The company is engaged in the design, development, and commercialization of medical devices for the measurement of FeNO, a precise biomarker for type 2 inflammation which is present in asthma and COPD. Its device, NIOX VERO, is increasingly recognised by healthcare professionals as an important tool to improve the diagnosis, monitoring and management of asthma and COPD. It operates in single segment of NIOX relates to the portfolio of products used to improve asthma diagnosis, monitoring and management by measuring fractional exhaled nitric oxide (FeNO).
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 95
- Website
- https://www.niox.com
Valuation
|
Metric
|
CSSPF
|
|---|---|
Price/Earnings (Normalized) | 32.09 |
Price/Book Value | 4.32 |
Price/Sales | 6.01 |
Price/Cash Flow | 18.80 |
Price/Earnings
CSSPF
Financial Strength
|
Metric
|
CSSPF
|
|---|---|
Quick Ratio | 3.47 |
Current Ratio | 4.60 |
Interest Coverage | — |
Quick Ratio
CSSPF
Profitability
|
Metric
|
CSSPF
|
|---|---|
Return on Assets (Normalized) | 10.04% |
Return on Equity (Normalized) | 12.38% |
Return on Invested Capital (Normalized) | 10.63% |
Return on Assets
CSSPF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|zT#@P$ | LOCK|S&Z$p | $167B | |||
| Medtronic PLC
MDT
| LOCK|$@BrFPj | LOCK|<$#& | $111B | |||
| Stryker Corp
SYK
| LOCK|rB?!gYb< | LOCK|J& | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|tXj>^?C | LOCK|^&hvq | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|%KZGZ%$ | LOCK|F$<&t | $49B | |||
| DexCom Inc
DXCM
| LOCK|>$<&dTW? | LOCK|Y!VVx | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^y#v#@ | LOCK|kr | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|MsY | LOCK|H? | $23B | |||
| Steris PLC
STE
| LOCK|sCn#<# | LOCK|<c$!M | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|f#&k>Jrq | LOCK|$v | $17B |
United States